How can flutamide combined with an LHRH analogue affect bone mineral density and fracture risk?

Flutamide combined with an LHRH analogue can reduce bone mineral density and increase osteoporotic fracture risk, with fracture risk rising as combined androgen blockade continues and complications potentially worsened by existing age-related osteoporosis.